Anwar M. Hussain

机构：Eli Lilly (United States)

发表论文 1 篇 · 总被引 20 次 · h-index 1

代表论文

• Efficacy and safety of abemaciclib alone and with PI3K / mTOR inhibitor LY3023414 or galunisertib versus chemotherapy in previously treated metastatic pancreatic adenocarcinoma: A randomized controlled trial (2023 · Cancer Medicine · 被引 20)